Nihon Kohden Corporation (OTCMKTS:NHNKY) Sees Significant Decrease in Short Interest

Nihon Kohden Corporation (OTCMKTS:NHNKY – Get Free Report) was the recipient of a significant drop in short interest in the month of May. As of May 15th, there was short interest totaling 3,556 shares, a drop of 83.6% from the April 30th total of 21,619 shares. Based on an average daily trading volume, of 39,773 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the shares of the company are sold short.

Analysts Set New Price Targets

Separately, Zacks Research raised Nihon Kohden to a “hold” rating in a research report on Monday, April 27th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy”.

Get Nihon Kohden alerts:

View Our Latest Analysis on Nihon Kohden

Nihon Kohden Price Performance

Shares of OTCMKTS NHNKY opened at $9.08 on Thursday. Nihon Kohden has a 1-year low of $8.71 and a 1-year high of $14.21. The business’s fifty day moving average price is $9.40 and its two-hundred day moving average price is $10.36. The firm has a market capitalization of $1.55 billion, a PE ratio of 15.39 and a beta of 0.41.

Nihon Kohden (OTCMKTS:NHNKY – Get Free Report) last issued its earnings results on Thursday, May 14th. The company reported $0.34 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.10. Nihon Kohden had a return on equity of 9.48% and a net margin of 6.08%.The firm had revenue of $453.10 million for the quarter, compared to analyst estimates of $414.40 million. Equities research analysts expect that Nihon Kohden will post 0.61 earnings per share for the current fiscal year.

Nihon Kohden Company Profile

(Get Free Report)

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.

Featured Articles

• Five stocks we like better than Nihon Kohden
• Bath & Body Works Stock Surged Despite Falling Sales—Here’s Why
• Dick’s Sporting Goods Isn’t Done Winning Yet
• Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
• TeraWulf Bets on Power Infrastructure to Lead AI Build-Out

Receive News & Ratings for Nihon Kohden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nihon Kohden and related companies with MarketBeat.com's FREE daily email newsletter.